Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparability of input parameters in the German Retina.net ROP registry and the EU-ROP registry - An exemplary comparison between 2011 and 2021.

Acta ophthalmologica·2023
Same author

[Are "pachychoroid spectrum disorders" a topic for CME?]

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2021
Same author

[Cost unit accounting of strabismus surgery at a university eye hospital].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2020
Same author

Disc-foveal angle and ocular counterrolling as a key in its interpretation.

Archivos de la Sociedad Espanola de Oftalmologia·2019
Same author

Risk of aphakic glaucoma after pars plana-lensectomy with and without removal of the peripheral lens capsule.

Eye (London, England)·2019
Same author

[Treatment options for progressive myopia in childhood].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2019

Related Experiment Video

Updated: Jul 15, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

[Steroids for optic nerve diseases?].

W A Lagrèze1

  • 1Universitäts-Augenklinik Freiburg, 79106, Freiburg. mail@lagreze.de

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|May 9, 2007
PubMed
Summary

Steroid treatment for optic nerve diseases like optic nerve neuritis and traumatic optic neuropathy may not be effective and carries risks. High-dose steroids can be dangerous and their value is questionable for these conditions.

Area of Science:

  • Ophthalmology
  • Neurology

Background:

  • Optic nerve diseases are a significant cause of blindness.
  • Common conditions include optic nerve neuritis and traumatic optic neuropathy.
  • Steroids are a frequent treatment for these optic neuropathies.

Purpose of the Study:

  • To evaluate the efficacy and safety of steroid treatment for optic nerve diseases.
  • To assess the current evidence regarding high-dose steroid use in optic nerve neuritis and traumatic optic neuropathy.

Main Methods:

  • Review of recent clinical results and studies.
  • Analysis of treatment outcomes and side effects associated with steroid therapy.

Main Results:

  • High-dose steroid treatment for traumatic optic neuropathy shows no benefit and potential harm due to side effects.

More Related Videos

Minimally-invasive Technique for Injection into Rat Optic Nerve
07:34

Minimally-invasive Technique for Injection into Rat Optic Nerve

Published on: May 19, 2015

Transconjunctival Approach for Injection into the Rat Optic Nerve
02:33

Transconjunctival Approach for Injection into the Rat Optic Nerve

Published on: April 4, 2025

Related Experiment Videos

Last Updated: Jul 15, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

Minimally-invasive Technique for Injection into Rat Optic Nerve
07:34

Minimally-invasive Technique for Injection into Rat Optic Nerve

Published on: May 19, 2015

Transconjunctival Approach for Injection into the Rat Optic Nerve
02:33

Transconjunctival Approach for Injection into the Rat Optic Nerve

Published on: April 4, 2025

  • The effectiveness of high-dose steroids for optic nerve neuritis is also under scrutiny based on current findings.

    • Conclusions:

    • The utility of high-dose steroid treatment for traumatic optic neuropathy is doubtful.
    • Further investigation is needed to clarify the role and risks of steroid treatment in optic nerve neuritis.